Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TSU-68 plus TS-1 and cisplatin versus TS-1 and cisplatin in advanced gastric cancer
jRCT2080221290Phase 2
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of orantinib in gastric adenocarcinoma (2 arms), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
orantinib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on jRCT2080221290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221290.